Arcus Biosciences
Stock Forecast, Prediction & Price Target
Arcus Biosciences Financial Estimates
Arcus Biosciences Revenue Estimates
Arcus Biosciences EBITDA Estimates
Arcus Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $382.88M N/A | $112M -70.74% | $117M 4.46% | Avg: $171.86M Low: $43.99M High: $296.23M avg. 46.89% | Avg: $325.82M Low: $134.13M High: $610.05M avg. 89.58% | Avg: $341.74M Low: $140.69M High: $639.86M avg. 4.88% | Avg: $815.69M Low: $335.80M High: $1.52B avg. 138.68% |
Net Income
% change YoY
| $53M N/A | $-267M -603.77% | $-307M -14.98% | Avg: $-423.83M Low: $-471.38M High: $-241.24M avg. -38.05% | Avg: $-357.73M Low: $-469.90M High: $-95.46M avg. 15.59% | Avg: $-251.73M Low: $-537.20M High: $-59.20M avg. 29.63% | Avg: $78.79M Low: $18.53M High: $168.15M avg. 131.30% |
EBITDA
% change YoY
| $54.90M N/A | $-264M -580.83% | $-283M -7.19% | Avg: $-132.56M Low: $-228.49M High: $-33.93M avg. 53.15% | Avg: $-251.31M Low: $-470.54M High: $-103.46M avg. -89.58% | Avg: $-263.59M Low: $-493.53M High: $-108.51M avg. -4.88% | Avg: $-629.16M Low: $-1.17B High: $-259.01M avg. -138.68% |
EPS
% change YoY
| $0.76 N/A | -$3.71 -588.15% | -$4.15 -11.85% | Avg: -$4.64 Low: -$6.37 High: -$3.26 avg. -11.71% | Avg: -$3.68 Low: -$6.35 High: -$1.29 avg. 20.58% | Avg: -$3.4 Low: -$7.26 High: -$0.8 avg. 7.59% | Avg: $1.06 Low: $0.25 High: $2.27 avg. 131.30% |
Operating Expenses
% change YoY
| $328.63M N/A | $392M 19.28% | $457M 16.58% | Avg: $149.39M Low: $38.24M High: $257.50M avg. -67.31% | Avg: $283.22M Low: $116.59M High: $530.28M avg. 89.58% | Avg: $297.06M Low: $122.29M High: $556.20M avg. 4.88% | Avg: $709.04M Low: $291.89M High: $1.32B avg. 138.68% |
FAQ
What is Arcus Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 34.61% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -471.38M, average is -423.83M and high is -241.24M.
What is Arcus Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 70.01% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $43.99M, average is $171.86M and high is $296.23M.
What is Arcus Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 36.94% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$6.37, average is -$4.64 and high is $-3.26.
What is the best performing analyst?
In the last twelve months analysts have been covering Arcus Biosciences stock. The most successful analyst is Yigal Nochomovitz.